AXGN – AxoGen, Inc.
AxoGen, Inc.AXGN
$23.42Name : AxoGen, Inc.
Sector : Healthcare
Industry: Medical Devices
Mark. Cap: $1,080,183,936.00
EPSttm : -0.05
AxoGen, Inc.
$23.42
0.55%$0.13Float Short %
6.07
Margin Of Safety %
-36
Put/Call OI Ratio
0.09
EPS Next Q Diff
0.06
EPS Last/This Y
0.53
EPS This/Next Y
0.2
Price
23.55
Target Price
28.67
Analyst Recom
1.11
Performance Q
52.03
Relative Volume
0.51
Beta
1.07
Ticker: AXGN
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-10-20 | AXGN | 16.97 | 0.10 | 0.03 | 1921 |
| 2025-10-21 | AXGN | 17.49 | 0.10 | 0.02 | 1929 |
| 2025-10-22 | AXGN | 18.04 | 0.08 | 0.00 | 2161 |
| 2025-10-23 | AXGN | 18.05 | 0.08 | 0.06 | 2202 |
| 2025-10-24 | AXGN | 18.17 | 0.08 | 0.00 | 2249 |
| 2025-10-27 | AXGN | 17.77 | 0.07 | 0.54 | 2520 |
| 2025-10-28 | AXGN | 18.11 | 0.07 | 0.47 | 2519 |
| 2025-10-29 | AXGN | 22.21 | 0.09 | 0.07 | 2637 |
| 2025-10-30 | AXGN | 22.69 | 0.09 | 0.01 | 2827 |
| 2025-10-31 | AXGN | 22.21 | 0.09 | 0.24 | 2837 |
| 2025-11-03 | AXGN | 23.27 | 0.09 | 0.07 | 2842 |
| 2025-11-04 | AXGN | 23.76 | 0.08 | 0.41 | 2893 |
| 2025-11-05 | AXGN | 23.38 | 0.08 | 0.50 | 2895 |
| 2025-11-06 | AXGN | 23.99 | 0.08 | 0.00 | 2922 |
| 2025-11-07 | AXGN | 23.57 | 0.08 | 0.00 | 2935 |
| 2025-11-10 | AXGN | 23.92 | 0.08 | 0.83 | 2966 |
| 2025-11-11 | AXGN | 24.45 | 0.09 | 0.07 | 2991 |
| 2025-11-12 | AXGN | 24.09 | 0.09 | 0.00 | 3013 |
| 2025-11-13 | AXGN | 24.05 | 0.09 | 0.19 | 3010 |
| 2025-11-14 | AXGN | 23.55 | 0.09 | 0.63 | 3022 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-10-20 | AXGN | 16.97 | -2.9 | - | 0.26 |
| 2025-10-21 | AXGN | 17.48 | -2.9 | - | 0.26 |
| 2025-10-22 | AXGN | 18.05 | -2.9 | - | 0.26 |
| 2025-10-23 | AXGN | 18.05 | -2.9 | - | 0.26 |
| 2025-10-24 | AXGN | 18.17 | -2.9 | - | 0.26 |
| 2025-10-27 | AXGN | 17.74 | -2.9 | - | 0.26 |
| 2025-10-28 | AXGN | 18.08 | -2.9 | - | 0.26 |
| 2025-10-29 | AXGN | 22.23 | -2.9 | - | 0.26 |
| 2025-10-30 | AXGN | 22.68 | -2.9 | - | 0.26 |
| 2025-10-31 | AXGN | 22.22 | -2.9 | - | 0.26 |
| 2025-11-03 | AXGN | 23.27 | 10.7 | - | 0.30 |
| 2025-11-04 | AXGN | 23.78 | 10.7 | - | 0.30 |
| 2025-11-05 | AXGN | 23.38 | 10.7 | - | 0.30 |
| 2025-11-06 | AXGN | 23.99 | 10.7 | - | 0.30 |
| 2025-11-07 | AXGN | 23.57 | -8.6 | - | 0.30 |
| 2025-11-10 | AXGN | 24.00 | -8.6 | - | 0.30 |
| 2025-11-11 | AXGN | 24.46 | -8.6 | - | 0.30 |
| 2025-11-12 | AXGN | 24.10 | -8.6 | - | 0.30 |
| 2025-11-13 | AXGN | 24.04 | -8.6 | - | 0.30 |
| 2025-11-14 | AXGN | 23.55 | -8.6 | - | 0.30 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-10-20 | AXGN | -4.20 | 2.47 | 4.85 |
| 2025-10-21 | AXGN | -4.20 | 2.47 | 4.85 |
| 2025-10-22 | AXGN | -4.20 | 2.47 | 4.85 |
| 2025-10-23 | AXGN | -4.20 | 2.47 | 4.85 |
| 2025-10-24 | AXGN | -4.26 | 2.47 | 4.71 |
| 2025-10-27 | AXGN | -8.63 | 2.72 | 5.53 |
| 2025-10-28 | AXGN | -8.63 | 2.72 | 5.53 |
| 2025-10-29 | AXGN | -8.63 | 2.72 | 5.53 |
| 2025-10-30 | AXGN | -8.63 | 2.72 | 5.53 |
| 2025-10-31 | AXGN | -12.63 | 2.72 | 5.53 |
| 2025-11-03 | AXGN | -12.63 | 3.00 | 5.52 |
| 2025-11-04 | AXGN | -12.63 | 3.00 | 5.52 |
| 2025-11-05 | AXGN | -12.63 | 3.00 | 5.52 |
| 2025-11-06 | AXGN | -12.63 | 3.00 | 5.52 |
| 2025-11-07 | AXGN | -13.71 | 3.00 | 5.52 |
| 2025-11-10 | AXGN | -13.71 | 6.51 | 5.52 |
| 2025-11-11 | AXGN | -13.71 | 6.51 | 5.52 |
| 2025-11-12 | AXGN | -13.71 | 6.51 | 6.08 |
| 2025-11-13 | AXGN | -15.15 | 6.51 | 6.08 |
| 2025-11-14 | AXGN | -15.15 | 6.51 | 6.07 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.01
Avg. EPS Est. Current Quarter
0.06
Avg. EPS Est. Next Quarter
0.07
Insider Transactions
-15.15
Institutional Transactions
6.51
Beta
1.07
Average Sales Estimate Current Quarter
57
Average Sales Estimate Next Quarter
57
Fair Value
15.15
Quality Score
60
Growth Score
66
Sentiment Score
85
Actual DrawDown %
5.5
Max Drawdown 5-Year %
-84.6
Target Price
28.67
P/E
Forward P/E
48.89
PEG
P/S
5.06
P/B
8.99
P/Free Cash Flow
325.2
EPS
-0.05
Average EPS Est. Cur. Y
0.3
EPS Next Y. (Est.)
0.5
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-0.98
Relative Volume
0.51
Return on Equity vs Sector %
-28.6
Return on Equity vs Industry %
-19.7
EPS 1 7Days Diff
EPS 1 30Days Diff
0.03
EBIT Estimation
AxoGen, Inc.Sector: Healthcare
Industry: Medical Devices
Employees: 451
Axogen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments; and Axoguard HA+ Nerve Protector, a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating designed to provide short- and long-term protection for peripheral nerve injuries. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma. The company provides its products to hospitals, surgery centers, and military hospitals, plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. Axogen, Inc. is headquartered in Alachua, Florida.
stock quote shares AXGN – AxoGen, Inc. Stock Price stock today
news today AXGN – AxoGen, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch AXGN – AxoGen, Inc. yahoo finance google finance
stock history AXGN – AxoGen, Inc. invest stock market
stock prices AXGN premarket after hours
ticker AXGN fair value insiders trading